| 期 |
标题 |
文件 |
| 卷 31, 编号 38 (2024) |
1,3,4-Oxadiazole: An Emerging Scaffold to Inhibit the Thymidine Phosphorylase as an Anticancer Agent |
(Eng)
|
|
Murmu A., Banjare P., Matore B., Roy P., Singh J.
|
| 卷 31, 编号 18 (2024) |
A Comprehensive Review on the State of the Art of Breast Cancers in Italy |
(Eng)
|
|
Iacopetta D., Ceramella J., Catalano A., Rosano C., Mariconda A., Giuzio F., Bonofiglio D., Saturnino C., Longo P., Sinicropi M.
|
| 卷 31, 编号 17 (2024) |
A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma |
(Eng)
|
|
Wang T., Chen P., Li T., Li J., Zhao D., Meng F., Zhao Y., Zheng Z., Liu X.
|
| 卷 31, 编号 38 (2024) |
A Novel Gene Signature based on Immune Cell Infiltration Landscape Predicts Prognosis in Lung Adenocarcinoma Patients |
(Eng)
|
|
Ma C.
|
| 卷 31, 编号 32 (2024) |
A Novel Phytocolorant, Neoxanthin, as a Potent Chemopreventive: Current Progress and Future Prospects |
(Eng)
|
|
Parida S., Jena M., Behera A., Mandal A., Nayak R., Patra S.
|
| 卷 31, 编号 2 (2024) |
A Quinquennial Review of Potent LSD1 Inhibitors Explored for the Treatment of Different Cancers, with Special Focus on SAR Studies |
(Eng)
|
|
Sheikh K., Iqubal A., Alam M., Akhter M., Khan M., Ehtaishamul Haque S., Parvez S., Jahangir U., Amir M., Khanna S., Shaquiquzzaman M.
|
| 卷 31, 编号 12 (2024) |
A Review on Graphene Analytical Sensors for Biomarker-based Detection of Cancer |
(Eng)
|
|
Patil S., Patil N., Mahajan M., Madhavi V., Gopinath S., Ramanathan S., More M., Patil K.
|
| 卷 31, 编号 8 (2024) |
A Review on Shikonin and its Derivatives as Potent Anticancer Agents Targeted against Topoisomerases |
(Eng)
|
|
Olatunde O., Yong J., Lu C., Ming Y.
|
| 卷 31, 编号 30 (2024) |
A Review on the Anticancer Activity of Carbazole-based Tricyclic Compounds |
(Eng)
|
|
Zhang H., Zhang W., Zhu M., Awadasseid A.
|
| 卷 31, 编号 19 (2024) |
A Review on the Efficacy and Safety of Intrathecal Administration of Novel Medications for Leptomeningeal Metastases in Solid Cancers |
(Eng)
|
|
Jafari F., Nodeh M., Hosseinjani H., Baharara H., Azad S., Arasteh O., Johnston T., Sahebkar A.
|
| 卷 31, 编号 30 (2024) |
A Review on the use of Synthetic and Recombinant Antigens for the Immunodiagnosis of Tegumentary Leishmaniasis |
(Eng)
|
|
Silva K., Ribeiro A., Gandra I., Resende C., da Silva Lopes L., Couto C., de Araujo Freire V., Barcelos I., Pereira S., Xavier S., da Paz M., Giunchetti R., Chávez-Fumagalli M., Gonçalves A., Coelho E., Galdino A.
|
| 卷 31, 编号 26 (2024) |
A Structure-based Data Set of Protein-peptide Affinities and its Nonredundant Benchmark: Potential Applications in Computational Peptidology |
(Eng)
|
|
Wang S., Ye H., Shang S., Li Z., Peng Y., Zhou P.
|
| 卷 31, 编号 38 (2024) |
A Systematic Patent Review (2008-2023) for Treatment in Pregnancy |
(Eng)
|
|
Pereira K., Pacheco C., Alves I., Haas S.
|
| 卷 31, 编号 42 (2024) |
Acknowledgements to Reviewers |
(Eng)
|
|
|
| 卷 31, 编号 7 (2024) |
Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases |
(Eng)
|
|
Pi Z., Qiu X., Liu J., Shi Y., Zeng Z., Xiao R.
|
| 卷 31, 编号 40 (2024) |
Activation of Stimulator of Interferon Genes (STING): Promising Strategy to Overcome Immune Resistance in Prostate Cancer |
(Eng)
|
|
Alnukhali M., Altabbakh O., Farooqi A., Pollack A., Daunert S., Deo S., Tao W.
|
| 卷 31, 编号 6 (2024) |
Administration of Inhibitory Molecules through Nanoparticles in Breast Cancer Therapy |
(Eng)
|
|
Quijia C., Enríquez A., Zappia C., Peroni R., Chorilli M.
|
| 卷 31, 编号 31 (2024) |
Aducanumab in Alzheimers Disease: A Critical Update |
(Eng)
|
|
Ashique S., Sirohi E., Kumar S., Rihan M., Mishra N., Bhatt S., Gautam R., Singh S., Gupta G., Chellappan D., Dua K.
|
| 卷 31, 编号 23 (2024) |
Advances in Chitosan-based Drug Delivery Systems in Melanoma: A Narrative Review |
(Eng)
|
|
Dana P., Hallajzadeh J., Asemi Z., Mansournia M., Yousefi B.
|
| 卷 31, 编号 21 (2024) |
Advances in Drug Therapy for Gastrointestinal Stromal Tumour |
(Eng)
|
|
Liu J., Li J., Zhu Y., Jing R., Ding S., Zhang J., Zhao L., Chen Y., Shen J.
|
| 卷 31, 编号 13 (2024) |
Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine |
(Eng)
|
|
Dhanjal D., Singh R., Sharma V., Nepovimova E., Adam V., Kuca K., Chopra C.
|
| 卷 31, 编号 41 (2024) |
Advances in the Development of Carbonic Anhydrase Inhibitors as New Antiprotozoal Agents |
(Eng)
|
|
Ortiz-Perez E., Vazquez-Jimenez L., Paz-Gonzalez A., Delgado-Maldonado T., González-González A., Gaona-Lopez C., Moreno-Herrera A., Vazquez K., Rivera G.
|
| 卷 31, 编号 12 (2024) |
Advances in the Treatment of Autism Spectrum Disorder: Current and Promising Strategies |
(Eng)
|
|
Yenkoyan K., Ounanian Z., Mirumyan M., Hayrapetyan L., Zakaryan N., Sahakyan R., Bjørklund G.
|
| 卷 31, 编号 38 (2024) |
Advances of Oxidative Stress Impact in Periodontitis: Biomarkers and Effective Targeting Options |
(Eng)
|
|
Pouliou C., Piperi C.
|
| 卷 31, 编号 6 (2024) |
Aging and Diabetic Kidney Disease: Emerging Pathogenetic Mechanisms and Clinical Implications |
(Eng)
|
|
Chen Y., Kanwar Y., Chen X., Zhan M.
|
| 卷 31, 编号 33 (2024) |
AI: A New Solution for Old Issues of Carotid Atherosclerotic Plaque |
(Eng)
|
|
Boccatonda A., Cocco G., Schiavone C.
|
| 卷 31, 编号 8 (2024) |
Aldehyde Dehydrogenases as Promising Targets for Treating Toxic Aldehyde-related Diseases |
(Eng)
|
|
Chen Y., Li X.
|
| 卷 31, 编号 32 (2024) |
Alkaloids as Additional Weapons in the Fight against Breast Cancer: A Review |
(Eng)
|
|
Chahat ., Jha K., Bhatia R., Chawla P.
|
| 卷 31, 编号 20 (2024) |
An Investigation into the Effects of Chemical, Pharmaceutical, and Herbal Compounds on Neuroglobin: A Literature Review |
(Eng)
|
|
Hamedani S., Pourmasoumi M., Askari G., Bagherniya M., Sathyapalan T., Sahebkar A.
|
| 卷 31, 编号 33 (2024) |
An Investigation of Pharmacokinetic Interaction of Vericiguat with Apigenin based on a Newly Developed Ultra-performance Liquid Chromatography-tandem Mass Spectrometry Assay |
(Eng)
|
|
Zhang E., Chen C., Wang Y., Weng Q., Xu R., Lin J.
|
| 卷 31, 编号 28 (2024) |
An Update of Extracellular Vesicle Involvement in Different Steps of Cancer Metastasis and Targeting Strategies |
(Eng)
|
|
Mortezaee K., Majidpoor J.
|
| 卷 31, 编号 29 (2024) |
An Update on Glutathione's Biosynthesis, Metabolism, Functions, and Medicinal Purposes |
(Eng)
|
|
Gasmi A., Nasreen A., Lenchyk L., Lysiuk R., Peana M., Shapovalova N., Piscopo S., Komisarenko M., Shanaida M., Smetanina K., Antonyak H., Fira L., Lykhatskyi P., Fira D., Bjørklund G.
|
| 卷 31, 编号 19 (2024) |
An Update on Parkinsons Disease and its Neurodegenerative Counterparts |
(Eng)
|
|
Adam H., Gopinath S., Arshad M., Adam T., Subramaniam S., Hashim U.
|
| 卷 31, 编号 36 (2024) |
An Updated Review For Hyperuricemia and Gout Management; Special Focus on the Available Drug Delivery Systems and Clinical Trials |
(Eng)
|
|
Karantas I., Miliotou A., Siafaka P.
|
| 卷 31, 编号 23 (2024) |
An Updated Review on the Significance of DNA and Protein Methyltransferases and De-methylases in Human Diseases: From Molecular Mechanism to Novel Therapeutic Approaches |
(Eng)
|
|
Ghanbari M., Khosroshahi N., Alamdar M., Abdi A., Aghazadeh A., Feizi M., Haghi M.
|
| 卷 31, 编号 30 (2024) |
Anticancer Potential of ACEIs/ARBs Administration in Colorectal Cancer |
(Eng)
|
|
Wang X., Jing H.
|
| 卷 31, 编号 15 (2024) |
Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma |
(Eng)
|
|
Trojan A., Lone Y., Briceno I., Trojan J.
|
| 卷 31, 编号 24 (2024) |
Anti-gout and Urate-lowering Potentials of Curcumin: A Review from Bench to Beside |
(Eng)
|
|
Jafari-Nozad A., Jafari A., Yousefi S., Bakhshi H., Farkhondeh T., Samarghandian S.
|
| 卷 31, 编号 1 (2024) |
Anti-obesity Properties of Phytochemicals: Highlighting their Molecular Mechanisms against Obesity |
(Eng)
|
|
Poulios E., Koukounari S., Psara E., Vasios G., Sakarikou C., Giaginis C.
|
| 卷 31, 编号 18 (2024) |
Antiviral Compounds to Address Influenza Pandemics: An Update from 2016-2022 |
(Eng)
|
|
Romeo R., Legnani L., Chiacchio M., Giofrè S., Iannazzo D.
|
| 卷 31, 编号 9 (2024) |
Application of Nanoparticles for Efficient Delivery of Quercetin in Cancer Cells |
(Eng)
|
|
Homayoonfal M., Aminianfar A., Asemi Z., Yousefi B.
|
| 卷 31, 编号 26 (2024) |
Application of Quercetin and its Novel Formulations in the Treatment of Malignancies of Central Nervous System: An Updated Review of Current Evidence based on Molecular Mechanisms |
(Eng)
|
|
Jamshidi-Mouselou M., Hashemi A., Jamshidi-Mouselou M., Farkhondeh T., Pourhanifeh M., Samarghandian S.
|
| 卷 31, 编号 39 (2024) |
Application Research Progress of Nanomaterial Graphene and its Derivative Complexes in Tumor Diagnosis and Therapy |
(Eng)
|
|
Cui L., Fan L., Shen Z.
|
| 卷 31, 编号 40 (2024) |
Artificial Intelligence Application for Anti-tumor Drug Synergy Prediction |
(Eng)
|
|
Peng Z., Ding Y., Zhang P., Lv X., Li Z., Zhou X., Huang S.
|
| 卷 31, 编号 6 (2024) |
Association between Statins Types with Incidence of Liver Cancer: An Updated Meta-analysis |
(Eng)
|
|
Zhang X., Lou D., Fu R., Wu F., Zheng D., Ma X.
|
| 卷 31, 编号 25 (2024) |
Association of Cystatin C Level with All-cause Mortality in Patients with Liver Cirrhosis: A Meta-analysis |
(Eng)
|
|
Wang X., Xu W., Yao L., Jie Y., Gao Z., Fan Y.
|
| 卷 31, 编号 39 (2024) |
Association of Neurokinin-1 Receptor Signaling Pathways with Cancer |
(Eng)
|
|
Rodriguez F., Covenas R.
|
| 卷 31, 编号 21 (2024) |
Association of PD-L1 Expression with Clinicopathologic Characters in Gastric Cancer: A Comprehensive Meta-analysis |
(Eng)
|
|
Han Z., Wang N., Qiao Q., He X., Wang N.
|
| 卷 31, 编号 36 (2024) |
Bacterial Polyhydroxyalkanoates-based Therapeutics-delivery Nano-systems |
(Eng)
|
|
Durán-Lara E., Rafael D., Andrade F., G. O., Vijayakumar S.
|
| 卷 31, 编号 24 (2024) |
Berberine Decreases Thrombosis Potential Induced by a High-choline Diet by Inhibiting CutC Enzyme |
(Eng)
|
|
Qu H., Zhang Y., Shi J., Zhao Y., Gao J., Gao Z., Shi D.
|
| 卷 31, 编号 10 (2024) |
Berberine: Pharmacological Features in Health, Disease and Aging |
(Eng)
|
|
Gasmi A., Asghar F., Zafar S., Oliinyk P., Khavrona O., Lysiuk R., Peana M., Piscopo S., Antonyak H., Pen J., Lozynska I., Noor S., Lenchyk L., Muhammad A., Vladimirova I., Dub N., Antoniv O., Tsal O., Upyr T., Bjørklund G.
|
| 卷 31, 编号 13 (2024) |
Beyond the Dusty Fog: Local Eye Drop Therapy and Potentially New Treatment Alternatives in Pseudoexfoliative Glaucoma |
(Eng)
|
|
Zeppieri M., Musa M.
|
| 卷 31, 编号 26 (2024) |
Bile Acid-conjugate as a Promising Anticancer Agent: Recent Progress |
(Eng)
|
|
Rathod N., Mishra S.
|
| 卷 31, 编号 37 (2024) |
Biochemistry, Mechanistic Intricacies, and Therapeutic Potential of Antimicrobial Peptides: An Alternative to Traditional Antibiotics |
(Eng)
|
|
Dwivedi M., Parmar M., Mukherjee D., Yadava A., Yadav H., Saini N.
|
| 卷 31, 编号 25 (2024) |
Biogenic Carbon Quantum Dots: Synthesis and Applications |
(Eng)
|
|
Deb A., Chowdhury D.
|
| 卷 31, 编号 19 (2024) |
Biology of Tenascin C and its Role in Physiology and Pathology |
(Eng)
|
|
Abedsaeidi M., Hojjati F., Tavassoli A., Sahebkar A.
|
| 卷 31, 编号 28 (2024) |
Biomarkers for Diagnosing and Treating Fetal Growth Restriction |
(Eng)
|
|
Wu M., He J., Chen Y., Wan F., Tang H., Yin C., He H., Yu H., Yuan C.
|
| 卷 31, 编号 31 (2024) |
Blood-based microRNAs as Potential Diagnostic Biomarkers for Melanoma: A Meta-Analysis |
(Eng)
|
|
Aalami A., Abdeahad H., Mokhtari A., Aalami F., Amirabadi A., Aliabadi E., Pirzade O., Sahebkar A.
|
| 卷 31, 编号 41 (2024) |
Caffeic Acid Phenethyl Ester: A Potential Therapeutic Cancer Agent? |
(Eng)
|
|
Bjørklund G., Storchylo O., Peana M., Hangan T., Lysiuk R., Lenchyk L., Koshovyi O., Antonyak H., Hudz N., Chirumbolo S.
|
| 卷 31, 编号 32 (2024) |
Cancer Pathways Targeted by Berberine: Role of microRNAs |
(Eng)
|
|
Ali M., Mishra D., Singh R.
|
| 卷 31, 编号 25 (2024) |
Carbon Nanocomposites-based Electrochemical Sensors and Biosensors for Biomedical Diagnostics |
(Eng)
|
|
Kannan P., Maduraiveeran G.
|
| 卷 31, 编号 31 (2024) |
Cardiac Organoids: A 3D Technology for Disease Modeling and Drug Screening |
(Eng)
|
|
Zhu Y., Yang S., Zhang T., Ge Y., Wan X., Liang G.
|
| 卷 31, 编号 10 (2024) |
Cardiospecific Troponins as Laboratory Biomarkers of Myocardial Cell Injury in Hypertension: A Mini-Review |
(Eng)
|
|
Chaulin A.
|
| 卷 31, 编号 27 (2024) |
CAR-T Therapy in Relapsed Refractory Multiple Myeloma |
(Eng)
|
|
Ding H., Wu Y.
|
| 卷 31, 编号 13 (2024) |
CD155-TIGIT Axis as a Therapeutic Target for Cancer Immunotherapy |
(Eng)
|
|
Mu Y., Guan X.
|
| 卷 31, 编号 17 (2024) |
Chalcone Derivatives as Antibacterial Agents: An Updated Overview |
(Eng)
|
|
de Oliveira A., Cenci A., Gonçalves L., Thedy M., Justino A., Braga A., Meier L.
|
| 卷 31, 编号 7 (2024) |
Challenges of Natural Anticancer and Anti-inflammatory Agents |
(Eng)
|
|
Scotti M., Scotti L.
|
| 卷 31, 编号 14 (2024) |
Chemical Strategies towards the Development of Effective Anticancer Peptides |
(Eng)
|
|
Li C., Jin K.
|
| 卷 31, 编号 34 (2024) |
CircRNAs as a Novel Class of Potential Diagnostic Biomarkers in Bipolar Disorders |
(Eng)
|
|
Asemi R., Ebrahimi A., Hamblin M., Mirzaei H., Asemi Z.
|
| 卷 31, 编号 6 (2024) |
Circulating Levels of 5-HT and BDNF in Adults with Autism Spectrum Conditions: An Investigation in a Sample of Subjects with Autism Spectrum Disorder, their First-degree Relatives and Controls |
(Eng)
|
|
Carpita B., Stagnari R., Palego L., Baroni D., Massimetti G., Nardi B., Cremone I., Betti L., Giannaccini G., Dell'Osso L.
|
| 卷 31, 编号 14 (2024) |
Coenzyme Q10 for Enhancing Physical Activity and Extending the Human Life Cycle |
(Eng)
|
|
Bjørklund G., Semenova Y., Gasmi A., Ruwan Indika N., Hrynovets I., Lysiuk R., Lenchyk L., Uryr T., Yeromina H., Peana M.
|
| 卷 31, 编号 2 (2024) |
Cognitive Benefits of Sodium-Glucose Co-Transporters-2 Inhibitors in the Diabetic Milieu |
(Eng)
|
|
Yaribeygi H., Maleki M., Sathyapalan T., Rizzo M., Sahebkar A.
|
| 卷 31, 编号 27 (2024) |
Combining Mendelian Randomization Analysis and 3D-QSAR to Investigate the Effectiveness of a New Series of Hydroxyquinolines in Osteoarthritis |
(Eng)
|
|
Lian Z., Su K., Lu H., Qu C., Ma X.
|
| 卷 31, 编号 30 (2024) |
Comprehensive Analysis of Ligand-receptor Interactions in Colon Adenocarcinoma to Identify of Tumor Microenvironment Oxidative Stress and Prognosis Model |
(Eng)
|
|
Hu J., Zhu W., Wang W., Yue X., Zhao P., Kong D.
|
| 卷 31, 编号 17 (2024) |
Comprehensive scRNA-seq Analysis and Identification of CD8_+T Cell Related Gene Markers for Predicting Prognosis and Drug Resistance of Hepatocellular Carcinoma |
(Eng)
|
|
Cao L., Liu M., Ma X., Rong P., Zhang J., Wang W.
|
| 卷 31, 编号 26 (2024) |
Computational Methods and Artificial Intelligence in the Discovery and Development of Therapeutic Peptides and Beyond |
(Eng)
|
|
Huang J.
|
| 卷 31, 编号 20 (2024) |
Computational Protein Design - Where it goes? |
(Eng)
|
|
Xu B., Chen Y., Xue W.
|
| 卷 31, 编号 12 (2024) |
Construction of RNA Methylation Modification-immune-related lncRNA Molecular Subtypes and Prognostic Scoring System in Lung Adenocarcinoma |
(Eng)
|
|
Wang J., Shu J.
|
| 卷 31, 编号 19 (2024) |
Crosstalk between Oxidative Stress and Inflammation Induced by Ionizing Radiation in Healthy and Cancerous Cells |
(Eng)
|
|
Mohammadgholi M., Hosseinimehr S.
|
| 卷 31, 编号 24 (2024) |
Curcumin and its Derivatives Targeting Multiple Signaling Pathways to Elicit Anticancer Activity: A Comprehensive Perspective |
(Eng)
|
|
Fatima F., Chourasiya N., Mishra M., Kori S., Pathak S., Das R., Kashaw V., Iyer A., Kashaw S.
|
| 卷 31, 编号 41 (2024) |
Curcumin Derivatives Linked to a Reduction of Oxidative Stress in Mental Dysfunctions and Inflammatory Disorders |
(Eng)
|
|
Dhiman P., Malik N.
|
| 卷 31, 编号 33 (2024) |
Curcuminoid Chalcones: Synthesis and Biological Activity against the Human Colon Carcinoma (Caco-2) Cell Line |
(Eng)
|
|
Olender D., Sowa-Kasprzak K., Pawełczyk A., Skóra B., Zaprutko L., Szychowski K.
|
| 卷 31, 编号 21 (2024) |
Curcuminoids as Cell Signaling Pathway Modulators: A Potential Strategy for Cancer Prevention |
(Eng)
|
|
Noor A., Shafi S., Sehar N., Qadir I., Bilquees ., Rashid S., Arafah A., Rasool S., Dar N., Masoodi M., Rehman M.
|
| 卷 31, 编号 26 (2024) |
Current Computational Methods for Protein-peptide Complex Structure Prediction |
(Eng)
|
|
Yang C., Xu X., Xiang C.
|
| 卷 31, 编号 26 (2024) |
Current Development of Data Resources and Bioinformatics Tools for Anticoronavirus Peptide |
(Eng)
|
|
Li B., Li M., Lu C., Wu Y., Chen H., He B.
|
| 卷 31, 编号 35 (2024) |
Current Evidence on Dietary Factors and Kidney Allograft Function in Kidney Transplant Recipients: A Systematic Review |
(Eng)
|
|
Nosrati-Oskouie M., Salavatizadeh M., Ghorban Sabbagh M., Aghili-Moghaddam N., Tarighat-Esfanjani A., Sahebkar A.
|
| 卷 31, 编号 42 (2024) |
Current Targets and Future Directions of Positive Inotropes for Heart Failure |
(Eng)
|
|
Fairuz S., Ang C., Mraiche F., Goh J.
|
| 卷 31, 编号 25 (2024) |
Current Trends in the Development of Electrochemical Biosensor for Detecting Analytes from Sweat |
(Eng)
|
|
Singh A., Sharma A., Dubey A., Arya S.
|
| 卷 31, 编号 27 (2024) |
Current Understanding of Androgen Signaling in Prostatitis and its Treatment: A Review |
(Eng)
|
|
Cabeza M.
|
| 卷 31, 编号 22 (2024) |
Detection of Circulating Cell-free DNA to Diagnose Hepatocellular Carcinoma in Chinese Population: A Systematic Review and Meta-analysis |
(Eng)
|
|
Aalami A., Aalami F., Aliabadi E., Amirabadi A., Sahebkar A.
|
| 卷 31, 编号 17 (2024) |
Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction |
(Eng)
|
|
Li X., Lei J., Shi Y., Peng Z., Gong M., Shu X.
|
| 卷 31, 编号 41 (2024) |
Development and Validation of the Diagnostic Model of 7 Gene in Endometriosis |
(Eng)
|
|
Zhu R., Liu Y., Zhou J., Lv Z., Shi K., Xiong J.
|
| 卷 31, 编号 16 (2024) |
Development in the Inhibition of Dengue Proteases as Drug Targets |
(Eng)
|
|
Akram M., Hameed S., Hassan A., Khan K.
|
| 卷 31, 编号 5 (2024) |
Development of Neuroprotective Agents for the Treatment of Alzheimer's Disease using Conjugates of Serotonin with Sesquiterpene Lactones |
(Eng)
|
|
Neganova M., Liu J., Aleksandrova Y., Vasilieva N., Semakov A., Yandulova E., Sukocheva O., Balakin K., Klochkov S., Fan R.
|
| 卷 31, 编号 29 (2024) |
Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment |
(Eng)
|
|
Ma C., Cui S., Xu R.
|
| 卷 31, 编号 38 (2024) |
Differential Effect of 4H-Benzo[d] [1, 3]oxazines on the Proliferation of Breast Cancer Cell Lines |
(Eng)
|
|
Fraire-Soto I., Araujo-Huitrado J., Granados-López A., Segura-Quezada L., Ortiz-Alvarado R., Herrera M., Gutiérrez-Hernández R., Reyes-Hernández C., López-Hernández Y., Tapia-Juárez M., Negrete-Díaz J., Chacón-García L., Solorio-Alvarado C., López J.
|
| 卷 31, 编号 7 (2024) |
Dihydrofolate Reductase (DHFR) Inhibitors: A Comprehensive Review |
(Eng)
|
|
Sehrawat R., Rathee P., Khatkar S., Akkol E., Khayatkashani M., Nabavi S., Khatkar A.
|
| 卷 31, 编号 9 (2024) |
Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19) |
(Eng)
|
|
De S.
|
| 卷 31, 编号 16 (2024) |
Discovery of Novel Inhibitors of Cruzain Cysteine Protease of Trypanosoma cruzi |
(Eng)
|
|
Prates J., Lopes J., Chin C., Ferreira E., dos Santos J., Scarim C.
|
| 卷 31, 编号 30 (2024) |
Discovery of Pyroptosis-inducing Drugs and Antineoplastic Activity based on the ROS/ER Stress/Pyroptosis Axis |
(Eng)
|
|
Gan X., Xie J., Dong Z., Wu Y., Zeng X., Yang Z., Liu B., Zhu M., Wang B., Li W., Wang L., Zhang H., Wu J., Hu Y.
|
| 1 - 100 的 400 信息 |
1 2 3 4 > >> |
